GEN and GNMSF Related Headlines

Go Back

GEN and GNMSF Related Press Releases

Go Back

Jul 23, 2014 07:11AM Second Quarter 2014 Net Sales Figures for Arzerra(r)
Jul 18, 2014 09:18AM Genmab Announces Phase III Study of Daratumumab in Front Line Multiple Myeloma
Jul 14, 2014 09:59AM Genmab to Receive Milestone Payment in DuoBody Platform Collaboration with Janssen
Jul 7, 2014 10:23AM Genmab Reaches USD 25 Million Milestone in Daratumumab Collaboration with Janssen
Jul 3, 2014 09:38AM GSK and Genmab Receive EU Authorization for Arzerra(tm) (ofatumumab) as First-Line Treatment for Chronic Lymphocytic Leukemia (CLL) in Combination with Chlorambucil or Bendamustine for Patients Inelig
Jun 27, 2014 02:27PM GSK and Genmab announce top-line results from a Phase III study of ofatumumab versus physicians' choice for bulky fludarabine-refractory CLL
Jun 4, 2014 02:27AM Genmab Announces DuoBody and HexaBody Platform Collaboration With Undisclosed Biotechnology Company
May 30, 2014 11:04AM Genmab Announces Ofatumumab Development Plans in RRMS and NMO
May 23, 2014 09:21AM GSK and Genmab Receive CHMP Positive Opinion for Arzerra(tm) in Combination with Chlorambucil or Bendamustine as a First-line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL) Who Are Not
May 19, 2014 02:21PM GSK and Genmab Announce Topline Results from a Pivotal Head to Head Study of Ofatumumab in Combination With Chemotherapy vs Rituximab in Combination with Chemotherapy for the Treatment of Relapsed or
May 7, 2014 11:11AM Genmab Announces Financial Results for the First Quarter of 2014

GEN and GNMSF Related SEC Filings

Go Back